Alpha Crest Capital Management LLC Biogen Inc. Transaction History

Alpha Crest Capital Management LLC

$0
Q4 2022

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $1.57 Million - $1.86 Million	-8,355 Reduced 71.61%	3,312 $675,000
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $1.12 Million - $1.41 Million	-5,784 Reduced 33.14%	11,667 $2.46 Million
Q4 2021 Feb 09, 2022	BUY	$223.92 - $287.77 $2.1 Million - $2.7 Million	9,399 Added 116.73%	17,451 $4.19 Million
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $389,677 - $508,181	-1,377 Reduced 14.6%	8,052 $2.28 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $316,498 - $506,775	-1,222 Reduced 11.47%	9,429 $3.27 Million
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $802,949 - $940,702	3,305 Added 44.99%	10,651 $2.98 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $1.74 Million - $2.61 Million	7,346 New	7,346 $1.8 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $2.29 Million - $2.64 Million	-8,651 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$258.66 - $342.55 $1.48 Million - $1.96 Million	5,718 Added 194.95%	8,651 $2.32 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $1.91 Million - $2.42 Million	-7,099 Reduced 70.76%	2,933 $928,000
Q4 2019 Feb 12, 2020	SELL	$220.06 - $304.07 $1.16 Million - $1.6 Million	-5,275 Reduced 34.46%	10,032 $2.98 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $1.93 Million - $2.16 Million	8,869 Added 137.76%	15,307 $3.56 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $118,416 - $130,528	-540 Reduced 7.74%	6,438 $1.51 Million
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $1.2 Million - $1.88 Million	5,552 Added 389.34%	6,978 $1.65 Million
Q4 2018 Feb 11, 2019	BUY	$278.5 - $352.75 $397,141 - $503,021	1,426 New	1,426 $429,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.

Account